 | Up a level |
Catapano, A; Reiner, Z; De Backer, G; Graham, I; Taskinen, M; Wiklund, O; Agewall, S; Alegria, E; Chapman, M; Durrington, P; Erdine, S; Halcox, J; Hobbs, R; Kjekshus, J; Filardi, P; Riccardi, G; Storey, R; Wood, D; incl. Windecker S, (2011). Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis, 217(1), pp. 3-46. Amsterdam: Elsevier 10.1016/j.atherosclerosis.2011.06.028
Olson, F J; Schmidt, C; Gummesson, A; Sigurdardottir, Vilborg; Hulthe, J; Wiklund, O; Fagerberg, B (2008). Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis. Journal of internal medicine, 263(6), pp. 626-635. Blackwell Scientific Publications 10.1111/j.1365-2796.2008.01927.x
